ARTICLE Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non – Small-Cell Lung Cancer: An Individual Patient Data

Approximately one-third of all cancer-related deaths in Western countries are due to lung cancer. Non – small-cell lung cancer (NSCLC) represents 75 % – 80 % of lung cancer cases and accounts for approximately 1.2 million new cases worldwide each year ( 1)